Translation and validation of a French sleep questionnaire
Translation and Validation of the French Version of the Sleep Regularity Questionnaire: a New Tool to Address the the Challenge of Sleep Health
This study is testing a French version of a sleep questionnaire to see if it accurately measures sleep patterns in people with chronic insomnia or circadian rhythm disorders.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 50 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Bordeaux Academic / other |
| Locations | 1 site (Bordeaux) |
| Trial ID | NCT06727448 on ClinicalTrials.gov |
What this trial studies
This study aims to translate and validate the French version of the Sleep Regularity Questionnaire (SRQ), a tool designed to measure sleep irregularity and its impact on health. The research will involve patients with chronic insomnia or circadian rhythm disorders who will undergo a 14-day actimetry assessment to evaluate their sleep-wake patterns. The study will assess the reliability and validity of the French SRQ by comparing it to established measures of sleep regularity. The findings could provide valuable insights into the relationship between sleep patterns and overall health.
Who should consider this trial
Good fit: Ideal candidates for this study are French-speaking adults aged 18 and older with chronic insomnia or circadian rhythm disorders.
Not a fit: Patients with current psychiatric or neurological disorders, unstable cardiovascular or respiratory diseases, or those who are pregnant may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved assessment and management of sleep health in French-speaking populations.
How similar studies have performed: While the SRQ has been validated in English, this study represents a novel effort to adapt and validate it for French-speaking populations.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient ≥ 18 years of age * Patient with indication for 14-day actimetry for chronic insomnia or circadian rhythm disorder * Patients with an indication for 14-day actimetry to assess sleep-wake rhythms, for example prior to a 36-hour polysomnographic recording to diagnose central hypersomnia (narcolepsy or idiopathic hypersomnia). * Patient affiliated to or benefiting from a social security scheme * Patient with French as mother tongue, able to read and write French. * Patient able to understand and complete questionnaires independently * Patient informed and not opposed to participating in the study Exclusion Criteria: * Current psychiatric disorder (mood disorders, anxiety, psychosis, sleep-interfering use disorder) assessed during interview with investigator * Current neurological disorder affecting sleep (neurodegenerative disease, stroke, epilepsy) assessed during interview with investigator * Unstable cardiovascular or respiratory diseases * Pregnant or breast-feeding women * Adults under guardianship or curatorship * Opposition to participation expressed by healthy patient/volunteer
Where this trial is running
Bordeaux
- CHU de Bordeaux — Bordeaux, France (Recruiting)
Study contacts
- Study coordinator: Julien COELHO, Dr
- Email: Julien.coelho@chu-bordeaux.fr
- Phone: 05 57 82 01 72
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.